Back to CVE records
High 8.0HealthcarePublished Nov 20, 2018

CVE-2018-18561An issue was discovered in Roche Accu-Chek Inform II Base Unit / Base Unit Hub before 03.01.04 and CoaguChek / cobas h232 Handheld Base Unit before 03.01.04.

Updated under an hour ago ()

Does this affect you?

It affects roche accu-chek_inform_ii_firmware and 3 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.67%, higher than 51% of scored CVEs.

An issue was discovered in Roche Accu-Chek Inform II Base Unit / Base Unit Hub before 03.01.04 and CoaguChek / cobas h232 Handheld Base Unit before 03.01.04. Insecure permissions in a service interface may allow authenticated attackers in the adjacent network to execute arbitrary commands on the operating system.

CVSS
8.0 HIGH (v3.0, NVD)CVSS:3.0/AV:A/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Weakness (CWE)
Not given
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.67% (percentile 51)
Assigned by
mitre
NVD analysis
Modified
Record last updated
Aug 5, 2024
First seen by InfoSec Signals
Oct 12, 2026

Affected products

Affected products
roche accu-chek_inform_ii_firmware
roche:accu-chek_inform_ii_firmware
before 03.01.04
NVD
roche cobas_h_232_firmware
roche:cobas_h_232_firmware
before 03.01.04
NVD
roche coaguchek_firmware
roche:coaguchek_firmware
before 03.01.04
NVD
roche base_unit_hub_firmware
roche:base_unit_hub_firmware
before 03.01.04
NVD

References

  • x-refsource-misc, third-party-advisory, us-government-resource
  • vdb-entry, x-refsource-bid, third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.